nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CTSK—skull—pharynx cancer	0.104	0.178	CbGeAlD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP8—pharynx cancer	0.0711	0.171	CbGpPWpGaD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP8—pharynx cancer	0.0633	0.153	CbGpPWpGaD
Telaprevir—CTSK—Collagen degradation—MMP8—pharynx cancer	0.0552	0.133	CbGpPWpGaD
Telaprevir—ORM1—saliva—pharynx cancer	0.05	0.0854	CbGeAlD
Telaprevir—CELA1—head—pharynx cancer	0.0389	0.0664	CbGeAlD
Telaprevir—CTSK—mouth—pharynx cancer	0.0361	0.0617	CbGeAlD
Telaprevir—CTSS—mouth—pharynx cancer	0.0316	0.0541	CbGeAlD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0314	0.0755	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0279	0.0673	CbGpPWpGaD
Telaprevir—CTSS—neck—pharynx cancer	0.0271	0.0463	CbGeAlD
Telaprevir—CTSK—parotid gland—pharynx cancer	0.0251	0.043	CbGeAlD
Telaprevir—CMA1—lymphoid tissue—pharynx cancer	0.0251	0.0429	CbGeAlD
Telaprevir—CTSK—saliva-secreting gland—pharynx cancer	0.0241	0.0412	CbGeAlD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.023	0.0554	CbGpPWpGaD
Telaprevir—CTSS—parotid gland—pharynx cancer	0.022	0.0377	CbGeAlD
Telaprevir—CTSS—saliva-secreting gland—pharynx cancer	0.0211	0.0361	CbGeAlD
Telaprevir—CTSK—trachea—pharynx cancer	0.0186	0.0318	CbGeAlD
Telaprevir—CTSS—trachea—pharynx cancer	0.0163	0.0278	CbGeAlD
Telaprevir—CTSK—lymphoid tissue—pharynx cancer	0.0162	0.0277	CbGeAlD
Telaprevir—CTSK—spinal cord—pharynx cancer	0.0147	0.0251	CbGeAlD
Telaprevir—CTSS—lymphoid tissue—pharynx cancer	0.0142	0.0242	CbGeAlD
Telaprevir—CMA1—lymph node—pharynx cancer	0.0142	0.0242	CbGeAlD
Telaprevir—CMA1—Extracellular matrix organization—MMP8—pharynx cancer	0.0131	0.0317	CbGpPWpGaD
Telaprevir—CTSK—head—pharynx cancer	0.013	0.0223	CbGeAlD
Telaprevir—CTSS—spinal cord—pharynx cancer	0.0129	0.022	CbGeAlD
Telaprevir—CTSK—Extracellular matrix organization—MMP8—pharynx cancer	0.0117	0.0282	CbGpPWpGaD
Telaprevir—CTSS—head—pharynx cancer	0.0114	0.0195	CbGeAlD
Telaprevir—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0113	0.0273	CbGpPWpGaD
Telaprevir—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00992	0.0239	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00984	0.0237	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP8—pharynx cancer	0.00964	0.0232	CbGpPWpGaD
Telaprevir—CTSK—lymph node—pharynx cancer	0.00913	0.0156	CbGeAlD
Telaprevir—CTSK—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00877	0.0211	CbGpPWpGaD
Telaprevir—CTSS—lymph node—pharynx cancer	0.008	0.0137	CbGeAlD
Telaprevir—ORM1—spinal cord—pharynx cancer	0.00768	0.0131	CbGeAlD
Telaprevir—CTSS—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00722	0.0174	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—B4GALT5—pharynx cancer	0.00631	0.0152	CbGpPWpGaD
Telaprevir—ORM1—lymph node—pharynx cancer	0.00478	0.00817	CbGeAlD
Telaprevir—ALB—lymph node—pharynx cancer	0.00419	0.00716	CbGeAlD
Telaprevir—CMA1—Extracellular matrix organization—CDH1—pharynx cancer	0.00412	0.00993	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00398	0.00959	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—CDH1—pharynx cancer	0.00367	0.00885	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD79A—pharynx cancer	0.00339	0.00816	CbGpPWpGaD
Telaprevir—ABCB1—epithelium—pharynx cancer	0.00325	0.00555	CbGeAlD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00319	0.00768	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—CDH1—pharynx cancer	0.00303	0.00729	CbGpPWpGaD
Telaprevir—ABCB1—trachea—pharynx cancer	0.00287	0.00491	CbGeAlD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00279	0.00673	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD79A—pharynx cancer	0.00279	0.00672	CbGpPWpGaD
Telaprevir—ABCB1—lymphoid tissue—pharynx cancer	0.0025	0.00428	CbGeAlD
Telaprevir—ABCB1—spinal cord—pharynx cancer	0.00227	0.00388	CbGeAlD
Telaprevir—CTSK—Immune System—CD79A—pharynx cancer	0.00206	0.00495	CbGpPWpGaD
Telaprevir—ABCB1—head—pharynx cancer	0.00202	0.00345	CbGeAlD
Telaprevir—CTSK—Adaptive Immune System—CDH1—pharynx cancer	0.00189	0.00455	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00187	0.00451	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD79A—pharynx cancer	0.00169	0.00408	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00169	0.00408	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDH1—pharynx cancer	0.00155	0.00375	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00148	0.00358	CbGpPWpGaD
Telaprevir—ABCB1—lymph node—pharynx cancer	0.00141	0.00241	CbGeAlD
Telaprevir—CTSK—Innate Immune System—EGFR—pharynx cancer	0.00115	0.00277	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDH1—pharynx cancer	0.00114	0.00276	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—pharynx cancer	0.0011	0.00266	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—pharynx cancer	0.000947	0.00228	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—pharynx cancer	0.000943	0.00227	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—pharynx cancer	0.000909	0.00219	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—pharynx cancer	0.000847	0.00204	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—pharynx cancer	0.00067	0.00161	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—pharynx cancer	0.000619	0.00149	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CNDP2—pharynx cancer	0.000593	0.00143	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—pharynx cancer	0.000551	0.00133	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADH7—pharynx cancer	0.000536	0.00129	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000519	0.00125	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—pharynx cancer	0.000486	0.00117	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000482	0.00116	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADH1B—pharynx cancer	0.00047	0.00113	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADH7—pharynx cancer	0.00047	0.00113	CbGpPWpGaD
Telaprevir—ALB—Metabolism—B4GALT5—pharynx cancer	0.000449	0.00108	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000412	0.000992	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—pharynx cancer	0.000408	0.000982	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000394	0.000948	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000378	0.00091	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.00032	0.000771	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000317	0.000764	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000289	0.000697	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000254	0.000611	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000243	0.000584	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—pharynx cancer	0.000166	0.0004	CbGpPWpGaD
